Skip to main content
Phase 3 trials support lebrikizumab for moderate-to-severe atopic dermatitis
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Phase 3 trials support lebrikizumab for moderate-to-severe atopic dermatitis
User login
Username
Password
Reset your password
Concept
Lead
score
Dermatitis
1
1
Atopic Dermatitis
0
1
Monoclonal Antibody
0
1
Adolescent Medicine
0
0.65
Eczema
0
0.18
Specialty
Lead
score
Dermatology
1
1
Allergy & Clinical Immunology
0
1
Family Medicine/Primary Care
0
1
Edit Tags